10-Q: XBP Global Reports Q2 Loss Amid Revenue Growth & BPA Deal

Sentiment:

Quarterly Report


XBP Global Holdings, Inc. reported increased revenue for Q2 2025 but saw a higher net loss and reduced cash, while completing a significant acquisition of BPA post-period.

Capital raiseThe acquisition of BPA involved the issuance of 81,799,821 shares of Common Stock to holders of Allowed Notes Claims and for backstop and funding fees.New warrants to purchase 6,632,418 shares of Common Stock were issued to GP 3XCV LLC and XCV-STS, LLC.The company entered into exit financing arrangements for BPA, including $183 million of exit notes, $18 million in additional funding provided by XBP, $40 million of new loans (Gates Exit Facility), and a $150 million revolving credit facility (ABL Credit Agreement).The company explicitly states it may need to raise additional capital through debt or equity financing if existing cash and cash flows are insufficient to fund future activities or strategic transactions.
Worse than expectedNet loss from continuing operations for the six months ended June 30, 2025, increased to $(7.3) million from $(4.4) million in the prior year, indicating a worsening bottom-line performance.Total net loss for both the three and six months ended June 30, 2025, significantly increased compared to the prior year periods.Cash and cash equivalents decreased substantially from $12.1 million at December 31, 2024, to $6.1 million at June 30, 2025, reflecting a significant cash burn.Total liabilities and total debt increased, indicating higher financial leverage and potential future interest burdens.

Summary

  • Revenue from continuing operations increased by 17.6% to $39.4 million for the three months ended June 30, 2025, and by 7.5% to $77.0 million for the six months ended June 30, 2025, compared to the same periods in 2024.
  • Net loss from continuing operations was $(3.4) million for Q2 2025, a slight improvement from $(3.6) million in Q2 2024, but the six-month net loss from continuing operations worsened to $(7.3) million from $(4.4) million.
  • Total net loss for Q2 2025 was $(6.9) million, up from $(4.7) million in Q2 2024, and for the six months, it was $(11.2) million, compared to $(6.9) million in 2024.
  • Adjusted EBITDA from continuing operations significantly improved to $3.3 million for Q2 2025 (from $1.2 million in Q2 2024) and to $7.0 million for the six months (from $4.1 million in 2024).
  • Cash and cash equivalents decreased to $6.1 million as of June 30, 2025, from $12.1 million at December 31, 2024.
  • Total liabilities increased to $133.5 million as of June 30, 2025, from $109.4 million at December 31, 2024, and total debt rose to $32.3 million from $28.9 million.
  • The acquisition of Exela Technologies BPA, LLC (BPA), comprising American and Asian operations, was completed on July 29, 2025, for $1.00, following BPA's emergence from Chapter 11 bankruptcy.
  • In connection with the BPA acquisition, 81,799,821 shares of common stock were issued, increasing total outstanding shares to 117,515,972 as of August 14, 2025.
  • The company is no longer considered a controlled company under Nasdaq rules, with beneficial ownership dispersed among ETI (~27.1%), Gates Capital Management (~25.9%), and Avenue Capital (~9.8%).
  • A Shareholder Rights Agreement ('poison pill') was adopted to protect against unsolicited takeovers, granting rights exercisable if any shareholder acquires 30% or more of common stock.
  • The company is involved in ongoing litigation with 71 former employees in France, with an accrued liability of $0.8 million as of June 30, 2025, and an agreement in principle to settle with remaining claimants for $0.8 million.

Sentiment

Score: 4

Explanation: While revenue growth and Adjusted EBITDA improvement are positive, the significant increase in net losses, substantial decline in cash, and rising debt indicate ongoing financial challenges. The transformative BPA acquisition introduces both opportunities and integration risks, and the 'poison pill' suggests defensive positioning. The overall financial health for the period remains weak.

Positives

  • Revenue from continuing operations increased by 17.6% for the three months and 7.5% for the six months ended June 30, 2025, indicating top-line growth.
  • Adjusted EBITDA from continuing operations significantly improved to $3.3 million for Q2 2025 and $7.0 million for the six months, demonstrating operational efficiency gains.
  • Cost of revenue as a percentage of revenue decreased to 70.1% for Q2 2025 from 80.3% for Q2 2024, and to 70.0% for the six months from 76.8%, driven by automation and savings initiatives.
  • The strategic acquisition of BPA, completed post-period, expands the company's geographic reach to American and Asian markets and diversifies its business.
  • The company was in compliance with all financial covenants under its 2024 Facilities Agreement as of June 30, 2025.

Negatives

  • Net loss from continuing operations increased for the six months ended June 30, 2025, to $(7.3) million from $(4.4) million in 2024.
  • Total net loss significantly increased to $(6.9) million for Q2 2025 and $(11.2) million for the six months, compared to the prior year periods.
  • Cash and cash equivalents decreased by nearly 50% to $6.1 million as of June 30, 2025, from $12.1 million at December 31, 2024.
  • Total liabilities increased to $133.5 million, and total debt increased to $32.3 million, indicating higher financial leverage.
  • Selling, general and administrative expenses increased substantially by 73.5% for Q2 2025 and 64.7% for the six months, primarily due to bonus provisions, sales team investment, and legal expenses related to the BPA acquisition.
  • Related party expenses increased significantly due to higher service fees and offshoring efforts.
  • Ongoing legal proceedings related to former employees in France continue to incur costs and require settlements.

Risks

  • The company's performance is susceptible to political and economic conditions affecting demand for its services.
  • Exposure to cyber incidents, including data or security breaches, poses a significant threat.
  • Intense competition and alternative services could negatively impact business pricing and market share.
  • Failure to keep pace with technological developments and changes in industry trends could hinder growth.
  • Operational failures due to the unavailability or failure of third-party services on which the company relies.
  • Potential for intellectual property infringement claims.
  • Uncertainty regarding the availability of future funding on acceptable terms, particularly given the amount of company securities being offered.
  • Issuing additional equity securities to raise funds could lead to significant stockholder dilution.
  • Any new debt financing may involve restrictive covenants that could limit the company's business operations or ability to return capital to investors.
  • Inability to raise additional capital on acceptable terms may force the company to scale back, delay, or discontinue certain businesses or restrict operations.

Future Outlook

The company expects to spend approximately $2.0 million to $3.0 million on total capital expenditures and capitalizable contracts set-up costs over the next twelve months. It believes current cash, cash equivalents, and cash flows from financing activities are sufficient for working capital and capital expenditure requirements for at least twelve months. The company continually monitors compliance with debt covenants and believes it will remain in compliance for the next 12 months based on expected future performance, with mechanisms available for non-compliance. It may explore future strategic transactions, including joint ventures, business combinations, or asset acquisitions/dispositions, which may require additional funding through debt or equity financing.

Management Comments

  • Management believes the company's business ultimately advances digital transformation, improves market-wide liquidity, and encourages sustainable business practices.
  • Management believes the current assumptions, judgments and estimates used to determine amounts reflected in the condensed consolidated financial statements are appropriate.
  • Management believes the current cash, cash equivalents and cash flows from financing activities are sufficient to meet the company's working capital and capital expenditure requirements for a period of at least twelve months.
  • Management believes it will remain in compliance with all financial covenants for the next 12 months based on expected future performance.

Industry Context

XBP Global Holdings operates as a pan-European integrator of bills, payments, and related solutions, focusing on digital transformation for businesses across various industries like banking, healthcare, insurance, and the public sector. The recent acquisition of BPA expands its operational footprint into American and Asian markets, positioning it as a more global business process management (BPM) and technology solutions provider. The company's emphasis on automation and digital transformation aligns with broader industry trends towards efficiency, cost reduction, and cloud-based solutions in financial and business operations. The increased related party expenses for offshoring efforts also reflect a common industry strategy to optimize cost structures.

Comparison to Industry Standards

  • The filing does not provide specific comparable companies, projects, or results to benchmark against industry standards.
  • The company's revenue growth in continuing operations (17.6% for Q2, 7.5% for 6 months) suggests a positive trend in market penetration or demand for its digital transformation and payment processing services.
  • The significant increase in net loss and decrease in cash, despite revenue growth, indicates challenges in achieving profitability and managing liquidity, which may lag behind more mature or efficient industry peers.
  • The improvement in Adjusted EBITDA suggests underlying operational improvements, but these are offset by higher SG&A and related party expenses, which could be a point of divergence from industry best practices in cost control.
  • The strategic acquisition of BPA, including its emergence from Chapter 11, is a unique event that makes direct comparison to typical industry M&A activities challenging without more specific financial details of the combined entity's pro forma performance.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Authorized Shares IncreaseThe Third Amended and Restated Certificate of Incorporation was filed, increasing authorized shares to 400,000,000 shares of Common Stock and 20,000,000 shares of preferred stock.2025-07-29Provides greater flexibility for future equity raises and strategic transactions, but also enables potential dilution.
Controlled Company Status ChangeThe company is no longer considered a controlled company under Nasdaq rules, as beneficial ownership became dispersed post-BPA acquisition.2025-07-29May lead to changes in board independence requirements and corporate governance practices, aligning with non-controlled public company standards.
Shareholder Rights Agreement AdoptionThe board adopted a Shareholder Rights Agreement ('poison pill') granting one right per share, exercisable if any shareholder acquires 30% or more of common stock, allowing other holders to purchase additional shares at a discount.2025-07-29Designed to protect shareholders from unsolicited takeovers and maintain board control, potentially deterring hostile bids but also limiting shareholder ability to effect change.

Legal Proceedings

  • A group of 71 former employees filed a claim against a subsidiary related to dismissals from 2020 site closures in France. Summary proceedings upheld a $1.1 million claim, which the company appealed and paid to 66 of 67 claimants. Appeal proceedings for 15 remaining claimants are scheduled for September 8, 2025.
  • A substantive hearing decision was made on June 28, 2024, which the company has appealed. The court awarded $1.2 million to claimants who had not settled, with $1.0 million remaining to be paid by the company, plus up to three months of unemployment allowance.
  • As of May 21, 2025, the company agreed in principle to settle with the remaining 15 claimants for $0.8 million.
  • Accrued liabilities for this litigation were $0.8 million as of June 30, 2025, down from $1.0 million at December 31, 2024.

Related Party Transactions

  • Related party revenue from sales to ETI affiliates was $0.2 million for Q2 2025 and $0.3 million for the six months ended June 30, 2025.
  • Related party shared services from ETI affiliates amounted to $0.5 million for Q2 2025 and $1.4 million for the six months ended June 30, 2025.
  • Related party service fees from ETI affiliates were $0.3 million for Q2 2025 and $0.7 million for the six months ended June 30, 2025.
  • A new related party service agreement with Nventr, LLC (affiliated with the chairman) for AI analytics solutions resulted in an expense of $0.3 million for Q2 2025 and $0.4 million for the six months ended June 30, 2025, with $0.1 million and $0.2 million capitalized, respectively.
  • A new related party service agreement with HOV Services Ltd. (chairman also serves as executive chairman) for BPO and financial transaction processing solutions incurred an expense of $1.4 million for Q2 2025 and $1.5 million for the six months ended June 30, 2025.
  • Related party notes payable to ETI affiliates totaled $1.6 million as of June 30, 2025.
  • The company acquired membership interests in GP2 Holdings from ETI for 1,680,000 shares of XBP common stock (valued at $2.3 million), which held Exela 2026 Notes.

Stakeholder Impact

  • Shareholders: Experienced significant dilution due to the issuance of 81.8 million new shares for the BPA acquisition. The adoption of a 'poison pill' aims to protect against unsolicited takeovers, potentially limiting shareholder control over future strategic decisions.
  • Employees: Restructuring activities involved workforce reductions in certain regions, impacting employees. The ongoing French litigation highlights past employee disputes.
  • Customers: The acquisition of BPA expands the company's service offerings and geographic reach, potentially providing a broader suite of solutions and improved service continuity.
  • Creditors: The company's increased debt load and negative cash flow from operations could raise concerns, although management states compliance with covenants and available mechanisms for non-compliance.
  • Suppliers: The company's financial health and strategic shifts, including offshoring efforts, could influence relationships with existing and new suppliers.

Next Steps

  • Continue to evaluate additional capital expenditure needs.
  • Monitor compliance with financial covenants under the 2024 Facilities Agreement.
  • Engage in bona fide negotiations with lenders, refinance existing credit facilities, or cure potential breaches in case of non-compliance with debt covenants.
  • Continue settlement negotiations and attend the next hearing for the remaining claimants in the French employee litigation scheduled for September 8, 2025.
  • Integrate the acquired BPA operations and realize the anticipated benefits from the acquisition.
  • Evaluate the impact of new accounting standards (ASU No. 2023-09, ASU 2024-04, ASC 2024-03) on consolidated financial statements and footnote disclosures.
  • Potentially explore and evaluate future strategic transactions, including joint ventures, business combinations, or the acquisition/disposition of assets, which may require additional funding.

Key Dates

DateDescription
2020Closure of two production sites in France, leading to employee litigation.
2022-06-09Former employees filed complaints with the Labor Court in France.
2022-09-27First conciliation hearing at the Labor Court.
2022-10-09Merger Agreement dated, terminating previous management fee.
2022-12-13Conciliation hearing at the Labor Court.
2023-03-07Conciliation hearing at the Labor Court.
2023-0367 claimants filed application for summary proceedings for $1.1 million.
2023-04-11Summary proceedings hearing held.
2023-05-09Court issued decision upholding plaintiffs' claims for $1.1 million.
2023-09-05Conciliation hearing at the Labor Court.
2023-09-15Amendment to Secured Borrowing Facility (Amended Factoring Agreement) entered into.
2023-11-14Conciliation hearing at the Labor Court.
2023-11-29Closing of business combination (Reverse Recapitalization) with CF Acquisition Corp. VIII.
2023-11-30Company shares (XBP) and warrants (XBPEW) began trading on Nasdaq.
2023-12-05Conciliation hearing at the Labor Court.
2023-Q4Management approved a restructuring plan to realign business and strategic priorities.
2024-02-05Conciliation hearing at the Labor Court.
2024-02-16Substantive hearing held for French employee litigation.
2024-03-19Annual report on Form 10-K for year ended December 31, 2024, filed with SEC.
2024-06-13Stockholders approved XBP Europe's 2024 Stock Incentive Plan.
2024-06-26Maturity date for 2024 Term Loan Facilities (2028) and 2024 Revolving Credit Facility (2027).
2024-06XBP Europe, Inc. entered into Facilities Agreement with HSBC for Secured Credit Facility.
2024-06-28Decision made on substantive hearing for French employee litigation.
2024-Q3Certain on-demand printing operations classified as discontinued operations.
2025-01-01Consolidated total leverage ratio covenant step-down to 2.25 to 1.00.
2025-02-05Company entered into new related party service agreement with Nventr, LLC.
2025-02-13Compensation Committee approved grant of 1,967,449 restricted stock units and 30,951 stock options.
2025-02-18Company entered into new related party service agreement with HOV Services Ltd.
2025-03-20Compensation Committee approved accelerated vesting of certain awards.
2025-03-24Membership Interest Purchase Agreement (MI Agreement) executed with ETI for GP2 Holdings.
2025-03-31Compensation Committee approved accelerated vesting of certain awards.
2025-04-04Compensation Committee approved accelerated vesting of certain awards.
2025-05-21Company agreed in principle to settle with the remaining 15 claimants in French litigation for $0.8 million.
2025-06-30End of the reporting period for this Quarterly Report on Form 10-Q.
2025-07-03Wholly owned subsidiary agreed to purchase Exela Technologies BPA, LLC (BPA) and entered into a Transaction Support Agreement with BPA and affiliates.
2025-07-15Definitive proxy statement filed with the SEC regarding BPA acquisition.
2025-07-25Subsidiaries entered into an Amendment Agreement with HSBC UK Bank plc, extending termination date and amending covenants.
2025-07-29BPA consummated the transaction under the Plan and emerged from bankruptcy; acquisition transaction closed from an accounting perspective. Company's name changed to XBP Global Holdings, Inc. and authorized shares increased. Shareholder Rights Agreement adopted.
2025-08-07Deadline for Debtors to emerge from Chapter 11 for BPA acquisition conditions to be cleared.
2025-08-14Date of filing of this 10-Q report; 117,515,972 shares of common stock outstanding.
2025-08-15Record Date for dividend of one preferred share purchase right per outstanding share of Common Stock.
2025-09-08Next hearing scheduled for remaining claimants in French employee litigation.
2026-01-01Consolidated total leverage ratio covenant step-down to 2.00 to 1.00.
2027-04Expected payment deadline for remaining deferred payroll taxes, social security, and VAT.
2028-06-26Maturity date for 2024 Term Loan Facilities.
2028-11-29Expiration date for Private Placement, Forward Purchase, and Public Warrants.

Recommendation

hold

While XBP Global Holdings demonstrated revenue growth and improved Adjusted EBITDA in its continuing operations, the significant increase in net losses and a substantial decline in cash and cash equivalents are concerning. The recent transformative acquisition of BPA, while strategically expanding market reach, introduces considerable new debt and integration complexities. The adoption of a 'poison pill' suggests a defensive posture against potential takeovers, which can be viewed negatively by some investors. Given the mixed financial performance, increased leverage, and the inherent risks and opportunities associated with a major acquisition and integration, a 'hold' recommendation is appropriate. Investors should monitor the successful integration of BPA, the company's ability to return to profitability, and its cash flow generation in future periods before considering a 'buy' or 'sell' position.

Keywords

Business Process Management, Digital Transformation, Bills and Payments, Technology Solutions, SEC Filing, 10-Q, Quarterly Report, Financial Results, Acquisition, BPA, Exela Technologies, Corporate Governance, Risk Factors, Nasdaq, Shareholder Rights Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.